J. Shorr

Differential Effects of Donor Age in Liver Transplant Recipients Infected With Hepatitis B, Hepatitis C and Without Viral Hepatitis

R. Wiesner, J. Lake, R. Gordon, 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Randomized Safety Studies of Intravenous Perflubron Emulsion. I. Effects on Coagulation Function in Healthy Volunteers

P. Keipert, R. Noveck, K. Flaim, 2000, Anesthesia and analgesia.

Randomized safety studies of intravenous perflubron emulsion. II. Effects on immune function in healthy volunteers.

P. Keipert, R. Noveck, K. Flaim, 2000, Anesthesia and analgesia.

Perflubron as a gastrointestinal MR imaging contrast agent in the pediatric population

S. Don, N. Rollins, G. Bisset, 2005, Pediatric Radiology.

Mycophenolate mofetil combination therapy improves long‐term outcomes after liver transplantation in patients with and without hepatitis C

R. Wiesner, J. Lake, R. Gordon, 2005, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Randomized Safety Studies of Intravenous Perflubron Emulsion. II. Effects on Immune Function in Healthy Volunteers

P. Keipert, R. Noveck, K. Flaim, 2000 .

Safety and efficacy of TG101348, a selective JAK2 inhibitor, in myelofibrosis.

Catriona Jamieson, Ayalew Tefferi, Moshe Talpaz, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A Phase I Evaluation of TG101348, a Selective JAK2 Inhibitor, in Myelofibrosis: Clinical Response Is Accompanied by Significant Reduction in JAK2V617F Allele Burden.

D. Gilliland, J. Cortes, D. Gilliland, 2009 .

A Phase I Study of TG101348, An Orally Bioavailable JAK2-Selective Inhibitor, in Patients with Myelofibrosis

J. Cortes, D. Gilliland, R. Stone, 2008 .

Memory for the Rey-Osterrieth Figure: Perceptual clustering, encoding, and storage.

D. Delis, P. Massman, J. Shorr, 1992 .

In Vivo Lung Deposition of Hollow Porous Particles from a Pressurized Metered Dose Inhaler

Stephen P. Newman, S. Newman, A. Clark, 2002, Pharmaceutical Research.

407 Preliminary safety, pharmacokinetics/pharmacodynamics, and antitumor activity of XmAb20717, a PD-1 x CTLA-4 bispecific antibody, in patients with advanced solid tumors

Y. Najjar, A. Shields, S. Hu-Lieskovan, 2020 .

Preclinical and clinical studies on lymph node imaging using perflubron emulsion.

G. Wolf, P. Leese, K. Flaim, 1994, Artificial cells, blood substitutes, and immobilization biotechnology.

523 Preliminary clinical experience with XmAb20717, a PD-1 x CTLA-4 bispecific antibody, in patients with advanced solid tumors

Y. Najjar, A. Shields, S. Hu-Lieskovan, 2021, Journal for ImmunoTherapy of Cancer.